Select Page

US FDA Guidances Published in March 2022

by | Apr 3, 2022 | Guidances, Regulatory

US FDA has issued a series of guidance’s to assists the sponsor and applicant in the generic drug development. The March month has around 02 new/revised guidance under GDUFA and ICH provisions. The links of the guidance’s are provided below for quick review and...
Don`t copy text!